Fonadelpar

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFonadelpar
Drug Alias Name福那德帕FonadelparumNPS-005SJP-0035FK5ZAD810Z
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor delta agonists
TargetsPeroxisome proliferator-activated receptor delta
Therapy Area/IndicationsCorneal DiseasesXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSenju Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCorneal DiseasesXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A